The airway microbiome in cystic fibrosis: challenges for therapy

Laura J. Gillanders, J Stuart Elborn, Deirdre F Gilpin, T. Schneiders, Michael M Tunney

Research output: Contribution to journalLiterature review

5 Citations (Scopus)

Abstract

Although cystic fibrosis pulmonary infection is polymicrobial, routine laboratory methods focus on the detection of a small number of known pathogens. Recently, the use of strict anaerobic culture techniques and molecular technologies have identified other potential pathogens including anaerobic bacteria. Determining the role of all bacteria in a complex bacterial community and how they interact is extremely important; individual bacteria may affect how the community develops, possess virulence factors, produce quorum-sensing signals, stimulate an immune response or transfer antibiotic resistance genes, which could all contribute to disease progression. There are many challenges to managing cystic fibrosis lung infection but as knowledge about the airway microbiome continues to increase, this may lead to advances in the therapeutic management of the disease.
Original languageEnglish
Pages (from-to)645-660
Number of pages16
JournalTherapy
Volume8
Issue number6
DOIs
Publication statusPublished - Nov 2011

Fingerprint

Microbiota
Cystic Fibrosis
Bacteria
Quorum Sensing
Culture Techniques
Anaerobic Bacteria
Virulence Factors
Microbial Drug Resistance
Disease Management
Coinfection
Disease Progression
Technology
Lung
Therapeutics
Infection
Genes

Cite this

@article{47acc8d1389141c182c9acd4c842b25c,
title = "The airway microbiome in cystic fibrosis: challenges for therapy",
abstract = "Although cystic fibrosis pulmonary infection is polymicrobial, routine laboratory methods focus on the detection of a small number of known pathogens. Recently, the use of strict anaerobic culture techniques and molecular technologies have identified other potential pathogens including anaerobic bacteria. Determining the role of all bacteria in a complex bacterial community and how they interact is extremely important; individual bacteria may affect how the community develops, possess virulence factors, produce quorum-sensing signals, stimulate an immune response or transfer antibiotic resistance genes, which could all contribute to disease progression. There are many challenges to managing cystic fibrosis lung infection but as knowledge about the airway microbiome continues to increase, this may lead to advances in the therapeutic management of the disease.",
author = "Gillanders, {Laura J.} and Elborn, {J Stuart} and Gilpin, {Deirdre F} and T. Schneiders and Tunney, {Michael M}",
note = "Copyright 2011 Elsevier B.V., All rights reserved.",
year = "2011",
month = "11",
doi = "10.2217/thy.11.81",
language = "English",
volume = "8",
pages = "645--660",
journal = "Therapy",
issn = "1475-0708",
publisher = "Elsevier Inc.",
number = "6",

}

The airway microbiome in cystic fibrosis: challenges for therapy. / Gillanders, Laura J.; Elborn, J Stuart; Gilpin, Deirdre F; Schneiders, T.; Tunney, Michael M.

In: Therapy, Vol. 8, No. 6, 11.2011, p. 645-660.

Research output: Contribution to journalLiterature review

TY - JOUR

T1 - The airway microbiome in cystic fibrosis: challenges for therapy

AU - Gillanders, Laura J.

AU - Elborn, J Stuart

AU - Gilpin, Deirdre F

AU - Schneiders, T.

AU - Tunney, Michael M

N1 - Copyright 2011 Elsevier B.V., All rights reserved.

PY - 2011/11

Y1 - 2011/11

N2 - Although cystic fibrosis pulmonary infection is polymicrobial, routine laboratory methods focus on the detection of a small number of known pathogens. Recently, the use of strict anaerobic culture techniques and molecular technologies have identified other potential pathogens including anaerobic bacteria. Determining the role of all bacteria in a complex bacterial community and how they interact is extremely important; individual bacteria may affect how the community develops, possess virulence factors, produce quorum-sensing signals, stimulate an immune response or transfer antibiotic resistance genes, which could all contribute to disease progression. There are many challenges to managing cystic fibrosis lung infection but as knowledge about the airway microbiome continues to increase, this may lead to advances in the therapeutic management of the disease.

AB - Although cystic fibrosis pulmonary infection is polymicrobial, routine laboratory methods focus on the detection of a small number of known pathogens. Recently, the use of strict anaerobic culture techniques and molecular technologies have identified other potential pathogens including anaerobic bacteria. Determining the role of all bacteria in a complex bacterial community and how they interact is extremely important; individual bacteria may affect how the community develops, possess virulence factors, produce quorum-sensing signals, stimulate an immune response or transfer antibiotic resistance genes, which could all contribute to disease progression. There are many challenges to managing cystic fibrosis lung infection but as knowledge about the airway microbiome continues to increase, this may lead to advances in the therapeutic management of the disease.

U2 - 10.2217/thy.11.81

DO - 10.2217/thy.11.81

M3 - Literature review

AN - SCOPUS:81255198984

VL - 8

SP - 645

EP - 660

JO - Therapy

JF - Therapy

SN - 1475-0708

IS - 6

ER -